February 22, 2023 — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the fourth quarter and full year ended December 31, 2022. the company reported a wider Q4 net loss of $23.49 per diluted share, Analysts polled by Capital IQ forecast a per-share loss of $0.23. Revenue for the quarter ended Dec. 31 was $637.7 million, Analysts surveyed by Capital IQ projected $633.4 million. For Q1, the company expects a net loss of $0.45 to $0.55 per share on revenue of $610 million to $625 million. Analysts polled by Capital IQ are looking for a per-share loss of $0.42 on revenue of $648.7 million. For 2023, the company said it expects a per-share net loss of $1.25 to $1.75 on revenue of $2.55 billion to $2.68 billion. Analysts surveyed by Capital IQ are expecting a per-share loss of $1.39 and revenue of $2.7